Biocentis Secures $19M To Advance Sustainable Insect Control Solutions

The funding round included a $13M Seed equity investment led by the Grantham Foundation for the Protection of the Environment (US) and Algebris Investments, along with a $6M grant from Wellcome.

Biocentis will use the funding to advance its initial solutions into field trials across the Americas and expand its platform to new applications.

Read Also - Vyntelligence Secures $30M Series B To Expand AI Video Intelligence Platform

Led by CEO Giorgio Rocca, the Imperial College London spin-out develops sustainable, AI-powered insect control solutions, simulating real-world biological systems to accelerate development and anticipate emerging insect-borne risks.

The company’s initial solutions target Aedes aegypti mosquitoes, which spread diseases like dengue, Zika, yellow fever and chikungunya, and Drosophila suzukii, a fruit fly threatening global crops. Biocentis says its programmable biology platform can be scaled to address a wide range of harmful species.

“For over a century, we have relied on chemical pesticides, but insects evolve faster than chemical interventions, and the collateral damage to people and the environment continues to mount,” said Giorgio Rocca, Co-founder and CEO of Biocentis. “Advances in genetics now let us control harmful insect populations with precision while preserving the health of surrounding ecosystems.”

About Biocentis

Founded 2022 Biocentis a life-science spin-out from Imperial College London, is reimagining insect control with a cutting-edge technology platform that delivers both environmental sustainability and exceptional effectiveness.